Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth stocks

      Health stocks

      Novo Nordisk and Eli Lilly Stock: Which Healthcare Giant Is the Best Investment for 2024?
      Investing News

      Novo Nordisk and Eli Lilly Stock: Which Healthcare Giant Is the Best Investment for 2024?

      February 8, 2024
      CVS Adjusts 2024 Profit Forecast Downward Due to Rising Medical Costs
      Investing News

      CVS Adjusts 2024 Profit Forecast Downward Due to Rising Medical Costs

      February 7, 2024
      AbbVie Boosts 2027 Sales Forecast for Immunology Drugs 
      Investing News

      AbbVie Boosts 2027 Sales Forecast for Immunology Drugs 

      February 2, 2024

       

      LATEST NEWS

      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025